Literature DB >> 1718287

Predominant role of neutrophils in the inactivation of alpha 2-macroglobulin in arthritic joints.

J J Abbink1, A M Kamp, E J Nieuwenhuys, J H Nuijens, A J Swaak, C E Hack.   

Abstract

We studied the state of alpha 2-macroglobulin (alpha 2M), an important inhibitor of cartilage-degrading proteinases, in relation to activation of neutrophils in 82 patients with several types of arthritis, including 52 with rheumatoid arthritis and 11 with osteoarthritis. Levels of total inactive alpha 2M (i alpha 2M), which comprises alpha 2M complexed to proteinases and alpha 2M inactivated by oxidation or hydrolysis, were measured with a monoclonal antibody specific for i alpha 2M. In addition, levels of alpha 2M complexed to proteinases were quantitated with specific assays. Neutrophil activation was assessed by measuring elastase-alpha 1-antitrypsin complexes and lactoferrin. In 83% of the 82 patients tested, the synovial fluid (SF) to plasma ratio of i alpha 2M exceeded 1, indicating an intraarticular generation. Levels of i alpha 2M significantly correlated with neutrophil numbers (P less than 0.0005) and with levels of elastase-alpha 1-antitrypsin complexes and of lactoferrin (P less than 0.00001 for both). Moreover, part of i alpha 2M consisted of alpha 2M complexed to elastase-like and chymotrypsin-like proteinases, presumably, neutrophil elastase and cathepsin G, respectively. However, the amount of i alpha 2M was approximately 10-fold larger than the amount complexed to these proteinases. In vitro inactivation of alpha 2M by activated neutrophils was only partly inhibitable by eglin C, a specific inhibitor of both elastase and cathepsin G. Release of reactive oxygen species was presumably responsible for the additional inactivation of alpha 2M, because eglin C completely abolished the inactivation of alpha 2M by cell-free supernatant of activated neutrophils. Thus, our results suggest a predominant role of neutrophils in the inactivation of alpha 2M in the SF of patients with inflammatory joint diseases. However, this inactivation could be explained only in part by the release of neutrophilic proteinases. We propose that the inactivation of alpha 2M in SF was due to the concerted action of both reactive oxygen species and lysosomal proteinases.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1718287     DOI: 10.1002/art.1780340910

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  11 in total

1.  MMP protein and activity levels in synovial fluid from patients with joint injury, inflammatory arthritis, and osteoarthritis.

Authors:  I Tchetverikov; L S Lohmander; N Verzijl; T W J Huizinga; J M TeKoppele; R Hanemaaijer; J DeGroot
Journal:  Ann Rheum Dis       Date:  2005-05       Impact factor: 19.103

2.  Is blood neutrophil-lymphocyte ratio an independent predictor of knee osteoarthritis severity?

Authors:  Özlem Taşoğlu; Hüma Bölük; Şule Şahin Onat; İrfan Taşoğlu; Neşe Özgirgin
Journal:  Clin Rheumatol       Date:  2016-01-16       Impact factor: 2.980

3.  Early supplemental α2-macroglobulin attenuates cartilage and bone damage by inhibiting inflammation in collagen II-induced arthritis model.

Authors:  Shengchun Li; Chuan Xiang; Xiaochun Wei; Xiaojuan Sun; Ruifang Li; Pengcui Li; Jian Sun; Dinglu Wei; Yong Chen; Yanxiang Zhang; Lei Wei
Journal:  Int J Rheum Dis       Date:  2019-01-04       Impact factor: 2.454

4.  Interaction of transforming growth factor-beta-1 with alpha-2-macroglobulin from normal and inflamed equine joints.

Authors:  N Coté; D R Trout; M A Hayes
Journal:  Can J Vet Res       Date:  1998-10       Impact factor: 1.310

5.  Identification of α2-macroglobulin as a master inhibitor of cartilage-degrading factors that attenuates the progression of posttraumatic osteoarthritis.

Authors:  Shaowei Wang; Xiaochun Wei; Jingming Zhou; Jing Zhang; Kai Li; Qian Chen; Richard Terek; Braden C Fleming; Mary B Goldring; Michael G Ehrlich; Ge Zhang; Lei Wei
Journal:  Arthritis Rheumatol       Date:  2014-07       Impact factor: 10.995

6.  Alpha-2-macroglobulin functions as an inhibitor of fibrinolytic, clotting, and neutrophilic proteinases in sepsis: studies using a baboon model.

Authors:  J P de Boer; A A Creasey; A Chang; J J Abbink; D Roem; A J Eerenberg; C E Hack; F B Taylor
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

7.  Targeted designed variants of alpha-2-macroglobulin (A2M) attenuate cartilage degeneration in a rat model of osteoarthritis induced by anterior cruciate ligament transection.

Authors:  Yang Zhang; Xiaochun Wei; Shawn Browning; Gaetano Scuderi; Lewis S Hanna; Lei Wei
Journal:  Arthritis Res Ther       Date:  2017-07-25       Impact factor: 5.156

8.  The synovial fluid proteome differentiates between septic and nonseptic articular pathologies.

Authors:  James R Anderson; Aibek Smagul; Deborah Simpson; Peter D Clegg; Luis M Rubio-Martinez; Mandy J Peffers
Journal:  J Proteomics       Date:  2019-04-25       Impact factor: 4.044

Review 9.  Alpha-2-Macroglobulin, a Hypochlorite-Regulated Chaperone and Immune System Modulator.

Authors:  Jordan H Cater; Mark R Wilson; Amy R Wyatt
Journal:  Oxid Med Cell Longev       Date:  2019-07-22       Impact factor: 6.543

10.  Protease-activated alpha-2-macroglobulin can inhibit amyloid formation via two distinct mechanisms.

Authors:  Amy R Wyatt; Patrick Constantinescu; Heath Ecroyd; Christopher M Dobson; Mark R Wilson; Janet R Kumita; Justin J Yerbury
Journal:  FEBS Lett       Date:  2013-01-23       Impact factor: 4.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.